Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Randomization	STARTED	Sirolimus (SRL) Conversion	393
Randomization	STARTED	Calcineurin Inhibitors (CNI) Continuation	214
Randomization	COMPLETED	Sirolimus (SRL) Conversion	389
Randomization	COMPLETED	Calcineurin Inhibitors (CNI) Continuation	210
Randomization	NOT COMPLETED	Sirolimus (SRL) Conversion	4
Randomization	NOT COMPLETED	Calcineurin Inhibitors (CNI) Continuation	4
Patients Dosed With Test Article	STARTED	Sirolimus (SRL) Conversion	389
Patients Dosed With Test Article	STARTED	Calcineurin Inhibitors (CNI) Continuation	210
Patients Dosed With Test Article	COMPLETED	Sirolimus (SRL) Conversion	249
Patients Dosed With Test Article	COMPLETED	Calcineurin Inhibitors (CNI) Continuation	187
Patients Dosed With Test Article	NOT COMPLETED	Sirolimus (SRL) Conversion	140
Patients Dosed With Test Article	NOT COMPLETED	Calcineurin Inhibitors (CNI) Continuation	23

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00086346/flow